Elvia Cowan, SVP, Finance & CAO at Vaxcyte, Inc. (PCVX), sold 5,495 shares at $58.59 ($322K) on 2026-03-11, disclosed to the SEC on 2026-03-11.
Seasonal sale ($322k) by SVP, Finance & CAO — this insider has traded PCVX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.32 | 495 | $29K | 9.1% |
| 2 | $58.59 | 2,500 | $146K | 45.4% |
| 3 | $58.59 | 2,500 | $146K | 45.4% |
| Total | $58.66 avg | 5,495 | $322K | 100% |
| Filing → |
| PCVX | SELL | 2026-03-18 | $210K | — | Filing → |
| PCVX | SELL | 2025-12-29 | $1.1M | — | Filing → |
| PCVX | SELL | 2024-09-05 | $538K | — | Filing → |